Stem cells have been introduced as new promising therapeutic agents in treatment of
degenerative diseases because of having high differentiation potential while maintaining the …

Due to the limited accessibility of the in vivo situation, the scarcity of the human tissue, legal
constraints, and ethical considerations, the underlying molecular mechanisms of disorders …

Mitochondrial dysfunction has been linked to many diseases, including organ degeneration
and cancer. Wharton's jelly‐derived mesenchymal stem cells provide a valuable source for …

Abstract Background and Aim Cell‐based therapy utilizing mesenchymal stem cells (MSCs)
is currently being investigated as a therapeutic agent for chronic wounds. There is no …

Several studies investigated the application of Mesenchymal stem cells (MSCs) for treating
spermatogenic disorders. Considering the limitation of MSC application, the present study …

Background Striae distensae is a disfiguring atrophic skin condition that impairs the body's
aesthetic image. Despite the variety of conducted studies, there is controversy regarding the …

Human cells, especially stem cells, need to communicate and interact with extracellular
matrix (ECM) proteins, which not only serve as structural components but also guide and …

Abstract Type 2 Diabetes Mellitus (T2DM) accounts for more than 90% of total diabetes
mellitus cases all over the world. Obesity and lack of balance between energy intake and …

Mesenchymal stem cells (MSCs) directly differentiate into neurons and endothelial cells after
transplantation, and their secretome has considerable potential for treating brain injuries …

Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) can be isolated from umbilical
cords which is abundant and easy to obtain. Due to their potent immunosuppressive …